Burning Rock Biotech Files 6-K for December 2024
Ticker: BNR · Form: 6-K · Filed: Dec 31, 2024 · CIK: 1792267
Sentiment: neutral
Topics: reporting, press-release
Related Tickers: BNR
TL;DR
Burning Rock Biotech (BNR) filed its Dec 2024 6-K, includes press release.
AI Summary
Burning Rock Biotech Limited filed a Form 6-K on December 31, 2024, for the month of December 2024. The filing includes a press release as Exhibit 99.1. The company's principal executive offices are located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Why It Matters
This filing indicates ongoing reporting activity for Burning Rock Biotech, providing updates to investors through a press release.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic information, not significant new financial data or strategic shifts.
Key Numbers
- 20241231 — Reporting Period End Date (Indicates the period covered by the filing.)
Key Players & Entities
- Burning Rock Biotech Limited (company) — Registrant
- Yusheng Han (person) — Chief Executive Officer
- 001-39316 (dollar_amount) — Commission File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the month of December 2024, including a press release as Exhibit 99.1.
Who is the Chief Executive Officer of Burning Rock Biotech Limited?
Yusheng Han is the Chief Executive Officer of Burning Rock Biotech Limited, as indicated by the signature on the filing.
What is the company's commission file number?
The company's commission file number is 001-39316.
Where are Burning Rock Biotech's principal executive offices located?
Burning Rock Biotech's principal executive offices are located at No. 5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Does Burning Rock Biotech file annual reports under Form 20-F or Form 40-F?
Burning Rock Biotech indicates that it files annual reports under Form 20-F.
Filing Stats: 148 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-12-31 06:05:25
Filing Documents
- d924958d6k.htm (6-K) — 8KB
- d924958dex991.htm (EX-99.1) — 4KB
- 0001193125-24-287054.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: December 31, 2024